Search

everythinglearnresearchcommunity

for

Search:↓

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

ErbB2 signaling is crucial for skin cell growth and cancer development in mice.

VEGF promotes hair follicle cell growth through the VEGFR-2/ERK pathway.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Deleting TNFα gene reduces skin cancer risk in certain mice.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

HPV8 E6 gene causes growth of certain skin stem cells.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Krt6a-Cre transgenic mice help study gene effects on hair follicle development and tumor suppression.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

TPA is about 50 times more effective at promoting tumors than MZ.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.